Neuronal and Motor Activity in the Basal Ganglia During a Synchronization-Continuation Hand Tapping Task in Patients with Parkinson’s Disease
WSSFN 2025 Interim Meeting. Abstract 0103.
DOI:
https://doi.org/10.47924/neurotarget2025546Abstract
Introduction: Deep brain stimulation (DBS) of the STN is used for Parkinson’s disease (PD) patients refractory to medications. One symptom that is not significantly improved by DBS is freezing of gait (FoG) which, is implicated in performance in the synchronization-continuation task (SCT). The SCT consists of tapping in time with an external cue (like a metronome) and then continuing to tap without the external cue, requiring a shift from external to internal representations of rhythm. Studies have shown that patients with PD exhibit motor hastening in the continuation phase, with higher magnitude of hastening correlated to severity of FoG. To better understand the relationship between rhythmic control in the STN, medication, and DBS, 15 PD patients underwent the SCT while having both their motor behaviour and neural activity recorded.
Method: Patients with DBS leads implanted in the STN underwent testing in four different conditions: M1S1 (Med ON/Stim ON), M0S0 (Med OFF/Stim OFF), M1S0 (Med ON/Stim OFF), and M0S1 (Med OFF/Stim ON), with Med OFF defined as 12hr off anti-Parkinson medication. Motor data was recorded using a triaxial accelerometer or a piezoelectric force detection device. Neural activity in the form of local field potentials was recorded using the PerceptTM technology.
Results: Preliminary analysis of 3 patients showed motor hastening across all conditions, with greater magnitude in M0S0 (0.20 Hz) than M1S1 (0.12 Hz). Beta power was elevated in OFF states and reduced by medication or stimulation, while peak frequencies remained stable. In M0S0, beta power was highest during the listening phase, suggesting desynchronization with motor initiation.
Discussion: Our findings align with prior reports of motor hastening in PD during the SCT. The greater hastening observed in M0S0 compared to M1S1 suggests that medication and DBS may help stabilize rhythmic motor output, while future analyses of M1S0 and M0S1 will clarify their individual effects. Spectral results also showed elevated beta power in M0S0 and suppression with medication or stimulation, consistent with existing literature.
Conclusions: The results thus far confirm that motor hastening in the SCT is a common experience for patients with PD, and indicate that dopaminergic medication and DBS may help to reduce the degree of hastening. Additionally, the differences in beta oscillatory power across the different phases of the SCT, when combined with the behavioural results of the SCT, may help to better describe the role of the STN in rhythmic control, and how it is affected by PD.
Metrics
References
Tanner CM, Ostrem JL. Parkinson’s Disease. New England Journal of Medicine. 2024;391(5):442-452. doi:https://doi.org/10.1056/nejmra2401857
Fahn, S. (2006). Levodopa in the treatment of Parkinson’s disease. In: Parvez, H., Riederer, P. (eds) Oxidative Stress and Neuroprotection. Journal of Neural Transmission. Supplementa, vol 71. Springer, Vienna. https://doi.org/10.1007/978-3-211-33328-0_1
Gandhi KR, Abdolreza Saadabadi. Levodopa (L-Dopa). Nih.gov. Published April 17, 2023. Accessed January 28, 2025. https://www.ncbi.nlm.nih.gov/books/NBK482140/
Hartmann CJ, Fliegen S, Groiss SJ, Wojtecki L, Schnitzler A. An update on best practice of deep brain stimulation in Parkinson’s disease. Therapeutic Advances in Neurological Disorders. 2019;12. doi:https://doi.org/10.1177/1756286419838096 van den
Munckhof P, Bot M, Schuurman PR. Targeting of the Subthalamic Nucleus in Patients with Parkinson’s Disease Undergoing Deep Brain Stimulation Surgery. Neurology and Therapy. 2021;10(1):61-73. doi:https://doi.org/10.1007/s40120-021-00233-8
Hutchison WD, Allan RJ, Opitz H, et al. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson’s disease. Annals of Neurology. 1998;44(4):622-628. doi:https://doi.org/10.1002/ana.410440407
Canessa A, Palmisano C, Isaias IU, Mazzoni A. Gait-related frequency modulation of beta oscillatory activity in the subthalamic nucleus of parkinsonian patients. Brain stimulation. 2020;13(6):1743-1752. doi:https://doi.org/10.1016/j.brs.2020.09.006
Brozova H, Barnaure I, Ruzicka E, Stochl J, Alterman R, Tagliati M. Short- and Long-Term Effects of DBS on Gait in Parkinson’s Disease. Frontiers in Neurology. 2021;12. doi:https://doi.org/10.3389/fneur.2021.688760
Tolleson CM, Dobolyi DG, Roman OC, et al. Dysrhythmia of timed movements in Parkinson׳s disease and freezing of gait. Brain Research. 2015;1624:222-231. doi:https://doi.org/10.1016/j.brainres.2015.07.041
Al‐Ozzi TM, Botero-Posada LF, Lopez AL, Hutchison WD. Single unit and beta oscillatory activities in subthalamic nucleus are modulated during visual choice preference. European Journal of Neuroscience. 2020;53(7):2220-2233. doi:https://doi.org/10.1111/ejn.14750
Alanazi FI, Al-Ozzi TM, Kalia SK, et al. Neurophysiological responses of globus pallidus internus during the auditory oddball task in Parkinson’s disease. Neurobiology of Disease. 2021;159:105490-105490. doi:https://doi.org/10.1016/j.nbd.2021.105490
Lenc T, Merchant H, Keller PE, Henkjan Honing, Varlet M, Nozaradan S. Mapping between sound, brain and behaviour: four-level framework for understanding rhythm processing in humans and non-human primates.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Daniel Henao Lopez, Adriana Lucia Lopez Rios, Juan Sebastian Saavedra Moreno, Carlos Anibal Restrepo Bravo, Carlos Ignacio Velez Arango, Luis Antonio Franco Vergara, Milad Lankarany, William Duncan Hutchison
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
